Northwell collaborates with Envetec to become first health care system in US to implement innovative clean technology to treat regulated medical waste

Northwell's Core Laboratory at the Center for Advanced Medicine (CFAM) will use Envetec GENERATIONS® ¹ technology to sustainably treat over 500,000 pounds of regulated medical waste annually onsite.

NEW HYDE PARK, N.Y. & BIRDHILL, Ireland--(BUSINESS WIRE)--Northwell Health, New York State's largest health care provider and private employer, and Envetec Sustainable Technologies Limited ("Envetec"), a pioneering cleantech company dedicated to eradicating the current unsustainable practices of treating regulated medical waste (also referred to as biohazardous or infectious waste), today announced the installation of GENERATIONS. This groundbreaking technology is designed for the safe and effective on-site treatment of regulated medical waste including single-use laboratory plastics, glass, PPE and sharps containers.

"Climate change is undeniably becoming a public health crisis that requires urgent action and leadership from hospitals," said Michael Dowling, President and CEO of Northwell. "As the largest hospital network and private employer in New York, Northwell Health is fully committed to leading the transition towards a sustainable healthcare future. Adopting state-of-the-art clean technologies such as GENERATIONS represents an important step forward in our climate goal of reducing greenhouse gas emissions by 50 percent by 2030."

The Center for Advanced Medicine houses Northwell's core laboratory, recognized as the largest commercial laboratory in New York. As the central testing hub for a vast network encompassing multiple hospitals, general practitioner networks, and local healthcare providers throughout New York State, it efficiently processes samples from over 20,000 patients daily.

Northwell's core laboratory is adopting GENERATIONS with plans to sustainably treat over 500,000 pounds of regulated medical waste annually onsite. This waste historically has required the conventional treatment and disposal methods of transportation, autoclaving and landfill. According to independent data comparing GENERATIONS to standard treatment of regulated medical waste at nine global sites, it is projected that GENERATIONS will significantly decrease waste-related Scope 3 emissions by as much as 90%.²

Laboratories worldwide are under increasing pressure to reduce their production of regulated medical waste, a substantial portion comprising plastics that can take up to 1,000 years to decompose in landfills. According to a recent publication in the New England Journal of Medicine, the U.S. health sector is responsible for an estimated 8.5% of U.S. carbon emissions.³

"Exploring cutting-edge solutions to reduce the carbon footprint of the healthcare system will have significant health, social, and economic benefits," said Donna Drummond, Senior Vice President, Chief Expense Officer, and Chief Sustainability Officer. “At Northwell, we have a responsibility to implement sustainable practices, and this includes a public pledge to increase waste recycling rates to 25% of total waste volume by 2027. To help us get there, we must collaborate across the entire supply chain and identify new technologies to support a more circular and sustainable waste management system."

Prior to installation, the GENERATIONS technology was approved by the US Environmental Protection Agency (EPA) and the New York State Department of Health.

“We are delighted to be partnering with one of the largest healthcare systems in the US as Northwell Health drives meaningful innovation to meet their climate goals," said Malcolm Bell, Chair and CEO of Envetec. "Enabling laboratories to break free from their reliance on transportation, autoclaving, incineration, and landfill requires a new standard in waste management. GENERATIONS treats biohazardous waste onsite and plays a crucial role in reducing Scope 3 emissions."

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 21 hospitals, about 900 outpatient facilities and more than 12,000 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 85,000 employees – 18,900 nurses and 4,900 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, X, Instagram and LinkedIn.

About Envetec GENERATIONS

Given the life-science industry's commitment to zero operational waste, including eliminating single-use plastic and the ability to recover waste through circular routes such as reuse and recycling, the standard treatment path has remained unchanged for almost 50 years. It involves removing the bagged, untreated waste by road freight for autoclaving and/or incineration and landfill.

GENERATIONS breakthrough technology safely and effectively treats biohazardous regulated medical waste including plastics, glass, PPE, sharps containers and other general laboratory consumables on-site.

The GENERATIONS technology simultaneously shreds and disinfects infectious waste and materials directly at the source which can then be recycled. GENERATIONS, which is non-thermal and utilizes a proprietary biodegradable chemical, converts laboratory-produced medical waste into a recyclable polymer flake that is entirely safe to transport for recycling. GENERATIONS is designed to help laboratories begin phasing out today’s unsustainable activities, including incineration, autoclaving, landfill and the public health risk associated with the transportation of biohazardous regulated medical waste.

About Envetec Sustainable Technologies

Envetec's vision is to create clean change with leading clean technology for the treatment and sustainable repurposing of biohazardous laboratory waste materials at source, significantly reducing dependency on landfill, incineration, road haul and autoclaving. Laboratories currently have no choice but to generate regulated medical waste.⁴ Our mission is to transform those choices by enabling laboratories to move towards zero waste.

____________________________

[1] GENERATIONS is subject to registered trademarks and trademark applications in the EU, UK, US and Japan.

[2] Envetec requested Carbon Action Consultants Ltd, a London based independent third-party assessor of sustainability, to perform a three-month evaluation and due diligence of the impact of the GENERATIONS technology on lowering carbon emissions. The study benchmarked the life cycle emissions of processing a fixed amount of regulated or biohazardous waste against different waste treatment methodologies including incineration, landfill and autoclaving. For more information visit www.envetec.com.

[3] Decarbonizing the U.S. Health Sector — A Call to Action, October 13, 2021, at NEJM.org.

[4] NHS clinical waste strategy, March 2023.